Rejuvel Bio-Sciences, Inc. (NUUU)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Rejuvel Bio-Sciences, Inc. (NUUU) trades at $0.00. Rejuvel Bio-Sciences, Inc. is a development stage company focused on producing and marketing skincare products under the Rejuvel brand. Market cap: $117,765, Sector: Consumer defensive.
Last analyzed: Mar 18, 2026Analyst Coverage for NUUU: NUUU does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates NUUU against Consumer Defensive peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
NUUU: 1/1 perspectives are bearish.
Rejuvel Bio-Sciences, Inc. (NUUU) Consumer Business Overview
Rejuvel Bio-Sciences, Inc. operates in the consumer defensive sector, focusing on skincare products and environmental solutions. The company's primary offering is the Rejuvel-branded skin cream, with future ambitions in water treatment technology, positioning it as a small player in the global personal care and environmental sectors.
What Is the Investment Thesis for NUUU?
Rejuvel Bio-Sciences, Inc. presents a high-risk, high-reward investment profile characteristic of a development stage company. With a market capitalization of $0.00B and a single-digit employee count, the company's valuation hinges on successful execution of its expansion plans into environmental solutions, alongside sustained growth in its skincare product line. A gross margin of 47.4% indicates potential profitability in its existing operations, but negative beta of -186.21 suggests extreme volatility. Key catalysts include securing contracts for its water treatment technology and expanding distribution channels for its Rejuvel skincare brand. Investors should closely monitor the company's ability to secure funding and navigate regulatory hurdles in both the skincare and environmental sectors. The company's success depends on effective commercialization and market acceptance of its products and services.
Based on FMP financials and quantitative analysis
NUUU Key Highlights
- Market Cap of $0.00B reflects its status as a micro-cap or nano-cap company.
- Gross Margin of 47.4% indicates potential profitability in its skincare operations.
- The company has only 1 employee, highlighting its early stage and reliance on external resources.
- Beta of -186.21 suggests extreme volatility and a negative correlation with the overall market.
- The company's focus on both skincare and environmental solutions provides diversification, but also requires expertise in distinct markets.
Who Are NUUU's Competitors?
NUUU is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| FACYF Fancl Corporation | $17.45 | +0.00% | $2.37B | 63 |
| SGI Somnigroup International Inc | $72.67 | +0.48% | $15.28B | 62 |
| ELF e.l.f. Beauty, Inc. | $61.15 | +0.77% | 4B | 59 |
| MIOFF Milbon Co., Ltd. | $52.60 | +0.00% | $1.71B | 58 |
| KCDMF Kimberly-Clark de México, S. A. B. de C. V. | $2.10 | -3.67% | $6.30B | 48 |
| KCDMY Kimberly-Clark de México, S. A. B. de C. V. | $10.66 | +4.00% | $6.41B | 48 |
| PG The Procter & Gamble Company | $149.61 | +0.86% | $348.38B | 48 |
| RAY Raytech Holding Limited Ordinary Shares (RAY) | $3.13 | -0.16% | $9.30M | 48 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are NUUU's Key Strengths?
- Proprietary Rejuvel-branded skincare products.
- Potential for innovative water treatment technology.
- Diversification into both skincare and environmental solutions.
- Gross margin of 47.4% indicates potential profitability.
What Are NUUU's Weaknesses?
- Development stage company with limited operating history.
- Small market capitalization and limited financial resources.
- High beta indicates extreme volatility.
- Reliance on a single product (Rejuvel skin cream) for current revenue.
What Could Drive NUUU Stock Higher?
- Securing contracts for water treatment technology.
- Expansion of distribution channels for Rejuvel skincare brand.
- Positive results from pilot projects for water treatment technology.
- Development of new skincare products and formulations.
- Pursuit of government contracts for environmental solutions.
What Are the Key Risks for NUUU?
- Competition from established players in the skincare and water treatment markets.
- Regulatory hurdles and environmental compliance requirements.
- Dependence on securing funding for research and development.
- Product liability claims related to skincare or water treatment technologies.
- Limited operating history and financial resources.
What Are the Growth Opportunities for NUUU?
- Expansion of Rejuvel Skincare Line: The global skincare market is projected to reach $180 billion by 2027. Rejuvel Bio-Sciences, Inc. can capitalize on this growth by expanding its product line to include complementary skincare products, such as cleansers, serums, and sunscreens. This expansion could target specific demographics or skin concerns, enhancing market penetration and brand recognition. The timeline for this expansion is within the next 1-3 years, contingent on securing additional funding and establishing strategic partnerships with distributors.
- Strategic Partnerships for Distribution: Rejuvel Bio-Sciences, Inc. can leverage strategic partnerships with established retailers and e-commerce platforms to expand its distribution network. Collaborating with major beauty retailers or online marketplaces can provide access to a broader customer base and enhance brand visibility. This approach can accelerate market penetration and reduce the costs associated with building a proprietary distribution network. The timeline for establishing these partnerships is within the next 12-18 months, requiring proactive engagement with potential partners and negotiation of favorable terms.
- Development of Proprietary Water Treatment Technology: The global water and wastewater treatment market is projected to reach $75 billion by 2028. Rejuvel Bio-Sciences, Inc.'s electron particle accelerator technology offers a potential competitive advantage in treating various water sources, including drinking water, wastewater, and industrial effluents. Successful development and commercialization of this technology could generate significant revenue streams and establish the company as a leader in innovative water treatment solutions. The timeline for commercializing this technology is within the next 3-5 years, contingent on securing regulatory approvals and demonstrating its effectiveness in pilot projects.
- Geographic Expansion into Emerging Markets: Emerging markets, such as Asia-Pacific and Latin America, represent significant growth opportunities for Rejuvel Bio-Sciences, Inc.'s skincare products. These markets are characterized by increasing disposable incomes and growing demand for personal care products. Entering these markets through strategic partnerships or targeted marketing campaigns can drive revenue growth and diversify the company's geographic footprint. The timeline for entering these markets is within the next 2-4 years, requiring careful market research and adaptation of products to local preferences.
- Securing Government Contracts for Environmental Solutions: Governments worldwide are investing heavily in upgrading water treatment infrastructure and addressing water scarcity challenges. Rejuvel Bio-Sciences, Inc. can pursue government contracts for its electron particle accelerator technology, providing a stable revenue stream and enhancing its credibility in the environmental solutions market. Securing these contracts requires demonstrating the technology's effectiveness, cost-efficiency, and compliance with environmental regulations. The timeline for securing government contracts is within the next 3-5 years, contingent on successful pilot projects and competitive bidding processes.
What Opportunities Does NUUU Have?
- Expansion of Rejuvel skincare line into complementary products.
- Strategic partnerships for distribution and market access.
- Commercialization of proprietary water treatment technology.
- Geographic expansion into emerging markets.
What Threats Does NUUU Face?
- Competition from established players in the skincare and water treatment markets.
- Regulatory hurdles and environmental compliance requirements.
- Dependence on securing funding for research and development.
- Potential for product liability claims related to skincare or water treatment technologies.
What Are NUUU's Competitive Advantages?
- Proprietary Rejuvel-branded skincare formulations.
- Potential competitive advantage in water treatment using electron particle accelerator technology.
- Focus on both skincare and environmental solutions provides diversification.
What Does NUUU Do?
Rejuvel Bio-Sciences, Inc., established in 2009 and headquartered in Miami, Florida, is a development stage company operating within the consumer defensive sector. Originally named Technology Applications International Corporation, the company rebranded in June 2015 to reflect its focus on bio-sciences. Currently, Rejuvel Bio-Sciences, Inc. is engaged in the production, distribution, and marketing of skincare products, primarily centered around its Rejuvel-branded skin cream. This product is sold worldwide, targeting consumers seeking advanced skincare solutions. Beyond skincare, Rejuvel Bio-Sciences, Inc. intends to expand into environmental management solutions. This involves developing, building, and selling systems that utilize electron particle accelerator technology for the treatment of drinking water, municipal and industrial wastewater, sludge, and produced water from oil and gas fracturing activities. This planned diversification aims to address the growing need for advanced water treatment technologies. The company's strategy involves leveraging its expertise to create innovative solutions for both the personal care and environmental sectors. As a development stage company, Rejuvel Bio-Sciences, Inc. is focused on establishing its market presence and expanding its product offerings.
What Products and Services Does NUUU Offer?
- Produces and distributes skincare products under the Rejuvel brand.
- Markets and sells skin cream worldwide.
- Aims to develop environmental management solutions.
- Plans to use electron particle accelerator technology for water treatment.
- Targets drinking water, municipal and industrial wastewater, and sludge treatment.
- Addresses produced water from oil and gas fracturing activities.
How Does NUUU Make Money?
- Generates revenue through the sale of Rejuvel-branded skincare products.
- Plans to generate revenue through the sale of environmental management solutions.
- Focuses on developing and commercializing innovative technologies for skincare and water treatment.
What Industry Does NUUU Operate In?
Rejuvel Bio-Sciences, Inc. operates in the consumer defensive sector, specifically within the household and personal products industry. This sector is characterized by relatively stable demand, even during economic downturns. The global skincare market is substantial, with continuous innovation and demand for anti-aging and specialized treatments. Simultaneously, the environmental solutions market, particularly water treatment, is experiencing growth driven by increasing environmental regulations and water scarcity concerns. Rejuvel Bio-Sciences, Inc. faces competition from established players in both sectors, requiring a differentiated approach to gain market share.
Who Are NUUU's Key Customers?
- Consumers seeking advanced skincare solutions.
- Municipalities and industrial clients requiring water treatment solutions.
- Oil and gas companies seeking solutions for produced water treatment.
NUUU Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
NUUU Latest News
No recent news available for NUUU.
NUUU Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for NUUU.
Price Targets
Wall Street price target analysis for NUUU.
NUUU MoonshotScore
What does this score mean?
The MoonshotScore rates NUUU's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
NUUU OTC Market Information
NUUU trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
Rejuvel Bio-Sciences, Inc. Consumer Defensive Stock: Key Questions Answered
What does Rejuvel Bio-Sciences, Inc. do?
Rejuvel Bio-Sciences, Inc. is a development stage company focused on producing, distributing, and marketing skincare products under the Rejuvel brand. Its primary product is a skin cream sold worldwide. The company also intends to develop and sell environmental management solutions that use electron particle accelerator technology for treating water and wastewater. This dual focus aims to address both the personal care market and the growing need for advanced water treatment technologies, positioning the company for potential growth in both sectors.
What do analysts say about NUUU stock?
There is currently no available analyst coverage or consensus on NUUU stock. As a development stage company with a market capitalization of $0.00B, Rejuvel Bio-Sciences, Inc. may not be actively tracked by major investment firms. Investors should conduct their own thorough due diligence and consider the company's financial condition, growth prospects, and risk factors before making any investment decisions. The company's future performance will depend on its ability to successfully commercialize its products and technologies.
What are the main risks for NUUU?
Rejuvel Bio-Sciences, Inc. faces several key risks typical of a development stage company. These include competition from established players in both the skincare and water treatment markets, regulatory hurdles and environmental compliance requirements, dependence on securing funding for research and development, and potential product liability claims. The company's limited operating history and financial resources also pose significant challenges. Investors should carefully consider these risks before investing in NUUU stock.
What are the key factors to evaluate for NUUU?
Evaluate NUUU on fundamentals, analyst consensus, and risk factors. Not financial advice.
How frequently does NUUU data refresh on this page?
NUUU prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven NUUU's recent stock price performance?
Rejuvel Bio-Sciences, Inc. (NUUU) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Proprietary Rejuvel-branded skincare products. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider NUUU overvalued or undervalued right now?
Valuing Rejuvel Bio-Sciences, Inc. (NUUU) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying NUUU?
Before investing in Rejuvel Bio-Sciences, Inc. (NUUU), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on publicly available sources and may be subject to change.
- The company is a development stage company with limited operating history.
- Financial data is limited and may not be indicative of future performance.